Corbus Pharmaceuticals I... (CRBP)
NASDAQ: CRBP
· Real-Time Price · USD
9.25
-0.38 (-3.95%)
At close: Aug 15, 2025, 3:59 PM
9.43
1.95%
After-hours: Aug 15, 2025, 04:56 PM EDT
Corbus Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | 1.35M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -881.71K | 97.32K | 136.56K | 647.82K |
Cost of Revenue | n/a | n/a | 146K | n/a | 200K | 151.69K | 147.98K | 152.81K | 158.34K | n/a | 374.22K | 374.8K | 370.38K | 368.45K | 233.88K | 8.32M | 11.27M | 10.72M |
Gross Profit | n/a | n/a | n/a | n/a | -200K | -151.69K | 1.2M | -152.81K | -158.34K | n/a | -374.22K | -374.8K | -370.38K | -368.45K | -1.12M | -8.22M | -11.13M | -10.07M |
Operating Income | -19.15M | -19.77M | -12.61M | -15.51M | -10.99M | -9.62M | -10.1M | -9.49M | -8.19M | -17.3M | -10.8M | -8.18M | -12.34M | -8.52M | -10M | -13.88M | -16.7M | -15.41M |
Interest Income | 1.31M | 1.68M | 3.55M | 1.19M | 906K | n/a | n/a | 763.36 | 232K | n/a | 640.95 | 541.89 | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -17.66M | -16.98M | -9.53M | -13.78M | -10M | -6.9M | -8.02M | -10.05M | -8.78M | -17.74M | -10.88M | -8.78M | -13.25M | -9.44M | -10.26M | -2.18M | -17.14M | -16.07M |
Net Income | -17.66M | -16.98M | -9.53M | -13.78M | -10M | -6.9M | -8.02M | -10.05M | -8.78M | -17.74M | -10.94M | -8.98M | -24.86M | -11.08M | -10.26M | -2.18M | -17.14M | -16.07M |
Selling & General & Admin | 3.96M | 4.13M | 3.82M | 4.7M | 3.92M | 3.71M | 2.98M | 2.94M | 3.94M | 3.91M | 4.55M | 4.07M | 4.84M | 5.23M | 4.23M | 5.28M | 5.57M | 5.34M |
Research & Development | 15.19M | 15.64M | 8.79M | 10.81M | 6.87M | 5.76M | 6.98M | 6.55M | 4.25M | 13.39M | 6.24M | 4.11M | 2.5M | 3.29M | 5.76M | 8.7M | 11.27M | 10.72M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 217.54K | 182.66K | n/a | 275.55K | 77.71K | -208.68K | -193.35K | 109.66K | 12.03M | -227.61K | -15.09K |
Operating Expenses | 19.15M | 19.77M | 12.46M | 15.51M | 10.79M | 9.47M | 9.96M | 9.49M | 8.19M | 17.3M | 10.8M | 8.18M | 7.34M | 8.52M | 10M | 13.97M | 16.84M | 16.06M |
Interest Expense | n/a | n/a | n/a | 381K | 652K | 177.01K | 707.01K | 763.36K | 1.01M | n/a | 640.95K | 541.89K | 490.34K | 458.91K | 390.9K | 391.87K | 401.17K | 646.55K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | -200K | -151.69K | -147.98K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | n/a | 19.77M | 12.61M | 15.51M | 10.99M | 9.62M | 10.1M | 9.49M | 8.19M | 17.3M | 10.8M | 8.18M | 7.34M | 8.52M | 10M | 13.97M | 16.84M | 16.06M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | 2.00 | n/a | n/a | n/a | n/a | 65.8K | 194.46K | 11.61M | 1.65M | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 12.24M | 12.2M | 12.18M | 12.01M | 2.81M | 2.81M | 4.42M | 4.42M | 4.28M | 4.18M | 4.17M | 4.17M | 4.17M | 4.17M | 4.17M | 4.17M | 3.88M | 3.88M |
Shares Outstanding (Diluted) | 12.24M | 12.2M | 12.18M | 12.01M | 2.81M | 2.81M | 4.42M | 4.42M | 4.28M | 4.18M | 4.17M | 4.18M | 4.18M | 4.17M | 4.17M | 4.17M | 3.88M | 3.88M |
EPS (Basic) | -1.44 | -1.39 | -0.78 | -1.15 | -3.55 | -2.45 | -1.81 | -2.27 | -2.05 | -4.24 | -2.62 | -2.15 | -5.96 | -2.66 | -2.46 | -0.52 | -4.42 | -4.14 |
EPS (Diluted) | -1.44 | -1.39 | -0.78 | -1.15 | -3.55 | -2.45 | -1.81 | -2.27 | -2.05 | -4.24 | -2.62 | -2.15 | -5.95 | -2.66 | -2.46 | -0.52 | -4.42 | -4.14 |
EBITDA | n/a | -16.9M | -9.38M | -13.25M | -9.14M | -9.47M | -9.96M | -9.14M | -8.03M | -17.12M | -10.61M | -7.99M | -7.15M | -8.32M | -9.49M | -13.01M | -16.32M | -14.99M |
EBIT | n/a | -16.98M | -9.53M | -13.4M | -9.35M | -9.62M | -10.71M | -9.29M | -8.19M | -17.3M | -10.8M | -8.24M | -7.34M | -8.52M | -10M | -13.88M | -16.7M | -15.41M |
Depreciation & Amortization | n/a | n/a | 146K | 152K | 200K | 151.69K | 147.98K | 152.81K | 158.34K | 181.87K | 374.22K | 374.8K | 370.38K | 368.45K | 375.15K | 418.6K | 420.94K | 424.55K |